Our previous study also demonstrated that miR-34b/c is directly regulated by FOXO3a and that FOXO3a-mediated transactivation of miR-34b/c inhibits WNT/β-catenin signaling and suppresses β-catenin-dependent EMT in prostate cancer [7]. This evidence concerns the gene FOXO3 and prostate carcinoma.